A clinical trial has found that a prescription form of the omega-3 fatty acid eicosapentaenoic acid (EPA) was associated with longer overall survival among patients undergoing surgery for colorectal ...

Incyte's INCB161734 KRAS G12D inhibitor posted 89% and 81% objective response rates in Phase I PDAC and CRC data at ESMO 2026 ...

AI drug discovery mesothelioma: Insilico Medicine's generative AI platform Chemistry42 produced ISM6331, an oral pan-TEAD ...

In a Phase 1 study, treatment with Incyte's KRAS G12D inhibitor in combination with standard-of-care chemotherapy elicited an ...

A scoping review of 14 studies finds that nurse-led education, continuity-of-care programs, and telehealth monitoring are the main strategies for managing the toxicities of targeted cancer therapies, ...

Oncolytics Biotech Inc. announced updated data from Cohort 4 of its Phase 1/2 GOBLET study evaluating pelareorep in combination with atezolizumab in patients with second-line or later squamous cell ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

A study combining database analyses, glioma tissue samples, and cell-line experiments reports that PCGF1 upregulates CCDC34, ...

At ESMO 2026, Natera’s oncology portfolio appeared in 25 abstracts, 9 of them oral; two studies were published in Nature ...

Cipla's bispecific ADC rolditamig deruxtecan demonstrates a remarkable 71% reduction in disease progression for late-stage ...

Congress is one of the biggest events on the cancer research calendar, where clinical results can reshape treatment decisions ...

Breast cancer is emerging as a major health challenge in Kashmir, with medical experts stressing the need for greater public awareness, early diagnosis and timely treatment to improve survival rates.